| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 02/09/2010 | US7659394 Substituted morpholine compounds for the treatment of central nervous system disorders |
| 02/09/2010 | US7659286 N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide |
| 02/09/2010 | US7659270 (1R)-2-((2S)-2-(5-(6-(4-(2-((2S)-1-((2R)-2-(dimethylamino)-2-phenylacetyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)phenyl)-3-pyridinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl) -N,N-dimethyl-2-oxo-1-phenylethanamine; inhibit the function of the non-structural proteins (NS5A) |
| 02/09/2010 | US7659231 (PER) fluoropolyether compounds |
| 02/09/2010 | CA2451240C Cyclic diamine compound with 6 membered ring groups |
| 02/09/2010 | CA2438704C Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 02/09/2010 | CA2413061C Serine protease inhibitors |
| 02/09/2010 | CA2201863C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors |
| 02/09/2010 | CA2192092C Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
| 02/04/2010 | US20100029639 Ion channel modulating compounds and uses thereof |
| 02/04/2010 | US20100029607 Substituted Piperazines as CB1 Antagonists |
| 02/04/2010 | US20100028936 Detection of cancer cells in vitro using sigma-2 receptor ligands as radiotracers |
| 02/04/2010 | US20100028807 Imide Compound and Chemically Amplified Resist Composition Containing The Same |
| 02/03/2010 | EP2149568A1 Aryl-sulphonamidic dimers as metalloproteases inhibitors |
| 02/03/2010 | CN101638398A Amidine compound capable of preparing gefitinib and preparation method thereof |
| 02/03/2010 | CN101638397A Method for synthesizing N-methylmorpholine with granular solid superacid as catalyst |
| 02/02/2010 | US7655684 1-(Urea-, thiourea- and cyanoguanidine-methylene)benzyl)imidaoles, treatment of neuronal disorders, especially Alzheimer's disease, Down Syndrome, Parkinson's disease and Huntington's disease |
| 02/02/2010 | US7655649 Inhibitors of Akt activity |
| 02/02/2010 | CA2587149C Substituted n-sulfonylaminobenzyl-2-phenoxyacetamide compounds |
| 02/02/2010 | CA2396158C Dipeptide nitrile cathepsin k inhibitors |
| 01/28/2010 | WO2010010080A1 Aryl-sulphonamidic dimers as metalloproteases inhibitors |
| 01/28/2010 | WO2010010079A1 Diagnostic agents selective against metalloproteases |
| 01/28/2010 | WO2010009508A1 Antiparasitic compounds |
| 01/28/2010 | WO2009132452A8 Diaryl-cyclylalkyl derivatives as calcium channel blockers |
| 01/28/2010 | WO2009124962A3 Sulfonamides |
| 01/28/2010 | WO2008083054A3 Radioactive ligands for cardiac beta1 adrenoreceptor for imaging congestive heart failure |
| 01/28/2010 | US20100022773 Apoptosis promoters |
| 01/27/2010 | EP2146978A1 Imatinib production process |
| 01/27/2010 | EP2146976A2 Compositions of tolperisone |
| 01/27/2010 | EP1438298B1 Piperazine derivatives with ccr1 receptor antagonist activity |
| 01/27/2010 | EP1343485B1 Drug delivery system comprising a lipid-based nitric oxide donor |
| 01/27/2010 | EP1303503B1 Aniline derivatives |
| 01/27/2010 | CN101633648A Preparation method of cinepazide |
| 01/27/2010 | CN101633647A Method for synthesizing alpha-azyl aryl alkyl ketone compound with high selectivity and high yield |
| 01/27/2010 | CN100584835C Novel medicinal salt for cinepazide and preparation method thereof |
| 01/27/2010 | CN100584834C Synthesis method for levorotatory citirizine dihydrochloride |
| 01/27/2010 | CN100584819C Substituted 4-aminocyclohexanol derivatives |
| 01/26/2010 | US7652059 1-methyl-4-trifluoromethyl-1H-pyrrole-3-carboxylic acid [2-(1,3-dimethylbutyl)phenyl]amide; protecting plants against infestation by phytopathogenic microorganisms |
| 01/26/2010 | US7652020 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 01/26/2010 | US7652017 Therapy for central nervous system, brain disorders |
| 01/26/2010 | US7652011 Treating chronic neuropathic or inflammatory pain; [(1-methyl-1H-pyrrol-2-yl)methyl][[1-[(4-pyrazin-2-ylpiperazin-1-yl)acetyl]-4-[3-trifluoromethyl)phenyl]piperid-4-yl]methyl]amine |
| 01/26/2010 | US7652003 Macrocyclic β-secretase inhibitors |
| 01/26/2010 | US7652002 9-aminoacyl tetracycline compounds and methods of use thereof |
| 01/26/2010 | US7652001 Lipophilic, potentiated ester derivatives of nucleoside/viricide derivatives; side effect reduction; viricides; antiproliferative agents; bone metabolism disorders; antimetobolic, -tumor agents and -carcinogenic agents; poxviruses; herpes viruses; influenza and hepatitis viruses |
| 01/26/2010 | CA2350031C N-arylsulfonylamino acid omega-amides |
| 01/26/2010 | CA2338854C Nitric esters and nitrate salts of specific drugs |
| 01/21/2010 | WO2009130735A4 Fatty acid derivatives for oral administration endowed with high paia- tability |
| 01/21/2010 | US20100016334 Pharmaceutical formulations containing dopamine receptor ligands |
| 01/20/2010 | EP2144879A2 Pyridonecarboxamides crop protection agents containing the same method for production and use thereof |
| 01/20/2010 | EP1758853B1 Glucagon receptor antagonists, preparation and therapeutic uses |
| 01/20/2010 | EP1202961B1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 01/20/2010 | CN101631781A Improved process for preparing ethyl (s)-2-ethoxy-4-[n-[1-(2- piperidinophenyl)-3-methyl-1-butyl]aminocarbonyl methyl]benzoate and use thereof for the preparation of repaglinide |
| 01/20/2010 | CN101628899A 1-(2-methoxypheny1)-4-[3-(naphthalene-1-oxy)-2-hydroxypropyl] piperazine optical isomer and salt thereof, preparation method and application |
| 01/19/2010 | US7649093 Naphthalene compounds as selective estrogen receptor modulators |
| 01/19/2010 | US7649092 Urea derivatives as calcium channel blockers |
| 01/19/2010 | US7649060 Benzoxazines, adducts of hydroxy-containing compounds, isocyanate compounds, phenolic compounds, epoxy resin, and polyether sulfone toughener; towpregs, adhesive films |
| 01/19/2010 | US7649055 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support |
| 01/19/2010 | US7649011 Inhibitors of human tumor-expressed CCXCKR2 |
| 01/19/2010 | US7649001 Fused benzene derivative and use |
| 01/19/2010 | US7648991 Schizophrenia, psychoses, drug abuse, drug dependence, alcoholism; anxiolytic and antidepressant agents; psychological and bipolar disorders; crystallization, methylation, precipitation, separation |
| 01/14/2010 | WO2010006085A1 Fatty acid acetylated salicylates and their uses |
| 01/14/2010 | WO2009132453A8 Cyclylamine derivatives as calcium channel blockers |
| 01/14/2010 | US20100010216 2-fluorinated acyl-3-aminoacrylonitrile derivative and method for producing the same |
| 01/14/2010 | US20100010004 Inhibitors of histone deacetylase |
| 01/14/2010 | US20100009988 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 01/14/2010 | CA2729186A1 Fatty acid acetylated salicylates and their uses |
| 01/13/2010 | EP2142499A1 Subsituted sulphonamides, process for their preparation, pharmaceutical composition comprising thereof and their use |
| 01/13/2010 | EP2142193A2 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition |
| 01/13/2010 | EP1575911B1 Biaromatic compounds which activate ppar-gamma type receptors and use thereof in cosmetic or pharmaceutical compositions |
| 01/13/2010 | EP1399414B1 Substituted tetracycline compounds for the treatment of malaria |
| 01/13/2010 | EP1144388B1 Acyl derivatives which treat vla-4 related disorders |
| 01/13/2010 | CN101624384A Method for preparing cinnamon piperazine |
| 01/13/2010 | CN100579957C Novel arylamidine derivative or salt thereof |
| 01/12/2010 | US7645799 thromboembolic and/or inflammatory disorders; 4-Aminomethyl-cyclohexanecarboxylic acid (1-biphenyl-3-yl-2-phenyl-ethyl)-amide; selective inhibitors of serine protease enzymes of the coagulation cascade and/or contact activation system; improved pharmacological properties, plasma kallikrein activity |
| 01/12/2010 | US7645797 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal |
| 01/12/2010 | US7645760 1-(4-Benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives |
| 01/12/2010 | US7645333 Aqueous composition and method for imparting resistance to stain absorption |
| 01/12/2010 | CA2511242C Inhibitors of human tumor-expressed ccxckr2 |
| 01/12/2010 | CA2407463C N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 01/12/2010 | CA2387675C Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 01/12/2010 | CA2276373C Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same |
| 01/07/2010 | WO2010001821A1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative and use of the pharmaceutical composition |
| 01/07/2010 | US20100004438 Diarylether derivatives as antitumor agents |
| 01/07/2010 | US20100004241 Non-imidazole aryloxyalkylamines |
| 01/07/2010 | US20100003260 Phenylpentadienoyl derivatives and their use as par 1 antagonists |
| 01/07/2010 | CA2729405A1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition |
| 01/06/2010 | EP2141153A2 Stereoselective alkylation of chiral 2-methyl-4 protected piperazines |
| 01/06/2010 | EP2141143A2 Stereoselective alkylation of chiral 2-methyl-4 protected piperazines |
| 01/06/2010 | EP2139877A1 Deuterated piperazine derivatives as anti-anginal compounds |
| 01/06/2010 | EP1891029B1 Organic compounds for the treatment of imflammatory or alleric conditions |
| 01/06/2010 | EP1062948B1 Remedies for non cardiogenic diastolic dysfunction |
| 01/06/2010 | CN100577633C CaSR antagonist |
| 01/05/2010 | US7642378 Lipid lowering biphenylcarboxamides |
| 01/05/2010 | US7642367 Diamino-functional chalcones |
| 01/05/2010 | US7642296 Photoinitiators |
| 01/05/2010 | US7642272 Cannabinoid receptor ligands |
| 01/05/2010 | US7642262 Arylipiperdinopropanol and arylipiperazinopropanol derivatives and pharmaceuticals containing the same |
| 01/05/2010 | CA2545999C 1,2-di(cyclic)substituted benzene compounds |
| 01/05/2010 | CA2318192C .beta.2-adrenergic receptor agonists |
| 12/31/2009 | US20090326221 New oxabispidine compunds useful in the treatment of cardiac arrhythmias |